Home
>
US Stocks
>
Akero Therapeutics Inc
Akero Therapeutics Inc
AKRO

Akero Therapeutics Inc (AKRO)

$21.245.18%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$20.62
Today Low/High
$20.62 / $21.24
52 Week Low/High
$17.66 / $37.94
Market Cap
$694.8M

Company Details

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, EFX, an engineered Fc-FGF21 fusion protein, is currently being evaluated in Phase 2 clinical trials as a potential treatment for NASH. Akero is headquartered in South San Francisco.
Organisation
Akero Therapeutics Inc
Headquaters
South San Francisco, California, United States
Employees
22
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Akero Therapeutics Inc (AKRO) share price today?

Can Indians buy Akero Therapeutics Inc (AKRO) shares?

How can I buy Akero Therapeutics Inc (AKRO) shares from India?

Can Fractional shares of Akero Therapeutics Inc (AKRO) be purchased?

What are the documents required to start investing in Akero Therapeutics Inc (AKRO) stocks?

We are a SEBI registered investement advisor